HFS
PFE icon

Hantz Financial Services’s Pfizer PFE Stock Holding History

Hantz Financial Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.06M Sell
168,432
-15,767
-9% -$412K 0.05% 221
2026
Q1 		$5.17M Sell
184,199
-2,486
-1% -$66.2K 0.08% 179
2025
Q4 		$4.65M Sell
186,685
-7,914
-4% -$200K 0.07% 204
2025
Q3 		$4.96M Sell
194,599
-300,149
-61% -$7.41M 0.08% 210
2025
Q2 		$12M Sell
494,748
-22,352
-4% -$521K 0.19% 94
2025
Q1 		$13.1M Buy
517,100
+2,916
+0.6% +$76.3K 0.23% 82
2024
Q4 		$13.6M Buy
514,184
+131,760
+34% +$3.57M 0.24% 81
2024
Q3 		$11.1M Sell
382,424
-2,933
-0.8% -$85.6K 0.2% 111
2024
Q2 		$10.8M Sell
385,357
-11,561
-3% -$318K 0.21% 112
2024
Q1 		$11M Buy
396,918
+30,785
+8% +$854K 0.21% 127
2023
Q4 		$10.5M Sell
366,133
-33,136
-8% -$1M 0.23% 127
2023
Q3 		$13.2M Buy
399,269
+5,015
+1% +$177K 0.34% 80
2023
Q2 		$14.5M Sell
394,254
-1,145
-0.3% -$44.6K 0.36% 75
2023
Q1 		$16.1M Buy
395,399
+5,823
+1% +$251K 0.44% 59
2022
Q4 		$20M Buy
389,576
+38,984
+11% +$1.87M 0.6% 38
2022
Q3 		$15.3M Buy
350,592
+6,956
+2% +$338K 0.53% 42
2022
Q2 		$18M Buy
343,636
+11,113
+3% +$566K 0.61% 32
2022
Q1 		$17.2M Sell
332,523
-29,780
-8% -$1.55M 0.51% 42
2021
Q4 		$21.4M Sell
362,303
-6,411
-2% -$318K 0.62% 35
2021
Q3 		$15.9M Buy
368,714
+39,065
+12% +$1.73M 0.52% 47
2021
Q2 		$12.9M Buy
329,649
+19,955
+6% +$776K 0.47% 50
2021
Q1 		$11.2M Buy
309,694
+23,423
+8% +$832K 0.47% 49
2020
Q4 		$10.5M Buy
286,271
+18,444
+7% +$677K 0.47% 52
2020
Q3 		$9.33M Sell
267,827
-5,057
-2% -$177K 0.48% 50
2020
Q2 		$8.47M Buy
272,884
+5,983
+2% +$203K 0.47% 44
2020
Q1 		$8.27M Buy
+266,901
New +$9.09M 0.57% 39

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hantz Financial Services's PFE Position: Q2 2026 in Review

Hantz Financial Services reduced its Pfizer (PFE) stake by 8.6% in Q2 2026, selling an estimated $412K and leaving 168,432 shares worth $4.06M. The position accounts for 0.05% of the portfolio, ranked #221.

Hantz Financial Services first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. The position peaked at $21.4M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hantz Financial Services held 168,432 shares of Pfizer worth $4.06M as of Q2 2026.
  • Hantz Financial Services sold 15,767 Pfizer shares in Q2 2026, an estimated $412K.
  • Pfizer made up 0.05% of Hantz Financial Services's portfolio in Q2 2026, its #221 holding.
  • Hantz Financial Services first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
  • Hantz Financial Services's Pfizer position peaked at $21.4M in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.